Non-immune factors in chronic rejection. Is there a role for hypolipemic drugs?

Annals of transplantation : quarterly of the Polish Transplantation Society

Volumn 2, Issue 2, 1997, Pages 65-69

  Paczek, L ^a   Bill, M ^a   Wyzgal J ^a   Gradowska, L ^a   Galazka Z ^a   Gaciong, Z ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; APOLIPOPROTEIN B; CHOLESTEROL; LIPOPROTEIN; MEVINOLIN;

ADULT; ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CLINICAL TRIAL; DRUG EFFECT; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOLOGY; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; RISK FACTOR;

ADULT; ANTILIPEMIC AGENTS; APOLIPOPROTEINS B; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHRONIC DISEASE; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; LIPOPROTEINS; LOVASTATIN; MALE; MIDDLE AGED; RISK FACTORS;

EID: 0031291802     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)